Canadian Society for Pharmaceutical Sciences
Société canadienne des sciences pharmaceutiques

Dr. Richard Weinshilboum of Mayo Clinic Presents Final Conference Plenary

Richard Weinshilboum, M.D., of the Mayo Clinic, Rochester, MN, will present the final plenary at the CSPS Conference ending May 25, speaking on Pharmacogenomics: Clinical Implementation and Future Challenges.  His presentation will provide selected examples of pharmacogenomic discovery, translation and clinical implementation.  A full session on Pharmacogenomic Implementation follows.

Dr. Weinshilboum holds Professorships in Cancer Genomics Research and Molecular Pharmacology & Experimental Therapeutics at the Mayo Clinic. He is director of the clinic’s Pharmacogenomics Program and co-Principle Investigator of their NIH Pharmacogenomics Research Network center. Dr. Weinshilboum has achieved international recognition for his research in pharmacogenomics and has authored over 430 scientific manuscripts in this field. He has been the recipient of numerous prestigious awards and honors throughout his career and has served on the Advisory Councils for the United States National Institute of General Medical Sciences and the National Human Genome Research Institute.

The Canadian Society for Pharmaceutical Sciences (CSPS) 2018 Conference, being held May 22-25, 2018, is a joint conference with Canadian Society of Pharmacology and Therapeutics (CSPT) and Canadian Chapter of Controlled Release Society (CC-CRS). The conference will also cover topics such as Immuno-Oncology, Regulatory Reform, Translational Medicine, and more. See Conference Program.

Reserve your seat by April 10th to save $200 on your Symposium registration.